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Abstract
Introduction: Recent years have witnessed a rapid expansion of efficacious biomedical HIV prevention technologies. Promising
as they may be, they are largely delivered through standard, clinic-based models, often in isolation from structural and beha-
vioural interventions. This contributes to varied, and often poor, uptake and adherence. There is a critical need to develop ana-
lytical tools that can advance our understandings and responses to the combination of interventions that affect engagement
with HIV prevention technologies. This commentary makes a call for practice-based combination HIV prevention analysis and
action, and presents a tool to facilitate this challenging but crucial endeavour.
Discussion: Models and frameworks for combination HIV prevention already exist, but the process of identifying precisely
what multi-level factors that need to be considered as part of a combination of HIV interventions for particular populations
and settings is unclear. Drawing on contemporary social practice theory, this paper develops a “table of questioning” to help
interrogate the chain and combination of multi-level factors that shape engagement with HIV prevention technologies. The tool
also supports an examination of other shared social practices, which at different levels, and in different ways, affect engage-
ment with HIV prevention technologies. It facilitates an analysis of the range of factors and social practices that need to be
synchronized in order to establish engagement with HIV prevention technologies as a possible and desirable thing to do. Such
analysis can help uncover local hitherto un-identified issues and provide a platform for novel synergistic approaches for action
that are not otherwise obvious. The tool is discussed in relation to PrEP among adolescent girls and young women in sub-
Saharan Africa.
Conclusions: By treating engagement with HIV prevention technologies as a social practice and site of analysis and public
health action, HIV prevention service planners and evaluators can identify and respond to the combination of factors and
social practices that interact to form the context that supports or prohibits engagement with HIV prevention technologies for
particular populations.
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1 | INTRODUCTION
Despite some successes in HIV prevention, 1.8 million people
were infected with HIV in 2017, and rates of infection grew
in more than 50 countries [1]. In sub-Saharan Africa, the
region worst affected by the HIV epidemic, more than a third
of new infections in 2017 occurred among young people (15
to 24 years) [1]. Although adolescent girls and young women
(15 to 24) only make up 10% of the population in sub-Saharan
Africa, they account for a quarter of all new HIV infections
[2]. This, coupled with a so-called “youth bulge” in sub-Saharan
Africa [3], has contributed to a sense of urgency to harness
recent biomedical and health service successes in HIV treat-
ment and rapidly expand the availability of biomedical HIV
prevention technologies.
Promising as these innovations may be, biomedical HIV pre-
vention technologies are largely implemented in isolation from
structural and behavioural interventions, with little recognition
of their synergies [4]. The difficulty of identifying the combina-
tion of biomedical, structural and behavioural interventions
required for strategic advantage and synergy is widely recog-
nized [4-6]. This challenge is compounded by the absence of
an analytical framework to help HIV prevention service plan-
ners and evaluators identify the combination of interventions
that work, under what circumstances, for whom, and with
which HIV prevention practices in focus. This commentary has
two aims. One, to argue that the biomedical turn in HIV pre-
vention presents both a need and an opportunity to conceptu-
alize practice-based combination prevention as an approach
for disentangling and responding to the range of behavioural,
biomedical and structural elements that interact with non-lin-
ear and multiplying effects to shape HIV prevention practices,
including engagement with HIV prevention technologies. Two,
to develop and demonstrate a tool for interrogating and
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responding to the chain, sequence or combination of factors
that affect engagement (or otherwise) with HIV prevention
technologies, as well as the role of other shared social prac-
tices.
2 | DISCUSSION
2.1 | The biomedical turn in HIV prevention
Remarkable progress has been made in expanding the port-
folio of biomedical HIV prevention technologies available to
young people. We now know that people living with HIV
(PLHIV) and on antiretroviral therapy can reach undetectable
levels of viral load, which prevents them from transmitting
HIV to their sexual partners [7]. This is referred to as treat-
ment as prevention (TasP). Antiretroviral drugs can also be
taken orally by HIV negative people as a pre-exposure pro-
phylaxis (PrEP) or post-exposure prophylaxis (PEP), signifi-
cantly reducing the risk of becoming infected [8,9].
Alternative ways of delivering antiretroviral drugs, such as
through vaginal rings [10], microbicide gels [11] or films
[12], are being tested in demonstration projects. Voluntary
medical male circumcision (VMMC) has proved efficacious,
lowering men’s risk of HIV infection by up to 60% [13].
These technologies, with the exception of VMMC, are con-
sidered “highly user-dependent” and adherence is repeatedly
stated as the strongest determinant of their effectiveness
[14,15].
Unfortunately, examples from across the globe highlight
varied uptake and adherence to these HIV prevention tech-
nologies, particularly among young people [2,16]. While
uptake and adherence to PrEP is generally high among cer-
tain groups of men who have sex with men in high-income
settings [17], disappointing levels of uptake and adherence to
PrEP among adolescent girls and young women (AGYW) is
widespread in sub-Saharan Africa [18,19]. Systematic reviews
have found PEP adherence to be generally poor, but particu-
larly so among adolescents [20]. Uptake of VMMC continues
to be slow in a number of sub-Saharan African countries [21],
although some countries, like South Africa [22], have wit-
nessed rapid increases of uptake in recent years. Successes in
VMMC scale-up, however, are often attributed to school-
based programmes targeting males 10 to 14, with young men
falling behind [23]. While treatment as prevention has demon-
strated its effectiveness, emerging evidence from South Africa
suggest that poor levels of antiretroviral drug adherence
among sexually active adolescents living with HIV may under-
mine treatment as a form of secondary prevention [24].
These varied outcomes suggest that populations and settings
appropriate and respond to HIV prevention technologies in
different ways. To optimize engagement with HIV prevention
technologies, we need to meet young people where they are
[25], and uncover local hitherto un-identified issues that
obstruct their uptake and engagement with these technolo-
gies, and identify novel approaches for action that are not
otherwise obvious.
Current emphasis on biomedical HIV prevention technolo-
gies confronts HIV prevention service planners and evaluators
with two challenges. One, to refrain from falling into the trap
of assuming that individuals are capable of making informed,
rational and unfettered choices for themselves, renewing
emphasis on the behaviour of individuals to make use of, and
consistently adhere to, HIV prevention technologies. Two, to
consider how a broader set of political, social, cultural and
ethical issues interact to shape the ability and decision of
young people to engage or disengage with HIV prevention
technologies. Herein lies the opportunity for a more focused
and practice-oriented approach to combination HIV preven-
tion. Rather than utilizing standard, clinic-based models to pro-
mote uptake and adherence – assuming young people to be
observers of specific behaviours following recommendations
from a healthcare provider – there is a need to recognize the
broader set of factors and other shared social practices (struc-
tural elements) that need to be synchronized to shape
engagement (behavioural elements) with HIV prevention tech-
nologies (biomedical elements). Practice-based combination
prevention, in an era of biomedical HIV prevention, is there-
fore about identifying and responding to the combination of
multi-level factors and other shared social practices whose
synergies create the context for particular populations that
supports or prohibits the practice of engaging with HIV
prevention technologies.
2.2 | Existing combination HIV prevention models
and frameworks
A few existing frameworks and models for combination HIV
prevention do exist, and include among others the Multiple
Domain Model [26], the Dynamic Social Systems Model [27],
the Network-Individual-Resource Model [28], the HIV pre-
vention cascade [29-31] and Complex Systems theory [4,32].
Each of these models and frameworks usefully highlight how
a range of factors influence each other in complex ways, with
implications for how individuals effectively deploy HIV pre-
vention technologies or behaviours. Useful as they are, the
process of identifying precisely what multi-level factors that
need to be considered as part of a combination HIV preven-
tion intervention for particular HIV prevention practices, pop-
ulations, settings and stages of the epidemic is unclear.
Interventions are often selected based on available evidence,
but key factors may be missed if HIV prevention service
planners and evaluators primarily draw on published evi-
dence from other contexts. Furthermore, pinpointing exactly
how structure and the social intersect with individual beha-
viour, affecting HIV prevention, is difficult and complex, ham-
pering both empirical research and combination prevention
interventions. This challenge has been noted by Susan Kippax
[33] who warns against HIV research and public health mod-
els that identify structural factors without interrogating the
mediating links between individual, community and societal
phenomena. Kippax [34] posits that it is through social prac-
tices we can understand and shape the relationship between
multiple levels of influence. For these reasons, I look to con-
temporary theories of practice and draw on the vocabulary
they have developed to propose a tool for analysing and
understanding how structure, individual behaviour and
biomedical technologies interact and come together to affect
engagement with HIV prevention technologies. The tool sup-
plements existing models and frameworks for combination
HIV prevention by sparking conversations and local research
to uncover new issues and connections between defining fac-
tors, which may lead to specific actions.
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2.3 | A “table of questioning” tool for practice-
based combination HIV prevention
Reckwitz [35: p. 249] defines a practice as “[a] routinized type
of behaviour which consists of several elements, intercon-
nected to one other: forms of bodily activities, forms of men-
tal activities, ‘things’ and their use, a background knowledge in
the form of understanding, know-how, states of emotion and
motivational knowledge.” According to this definition, agency
and the routine practice of engaging with HIV prevention
technologies is enabled by numerous overlapping factors of
influence coming together. These different factors form part
of the fabric of our everyday lives, across scales from the indi-
vidual to the macro as well as space and time. The factors
consist of, or give rise to, a broad domain of human activities,
which both reproduce or transform the factors themselves
and social practices that overlap to coordinate and synchro-
nize the practice of engaging (or otherwise) with HIV preven-
tion technologies. According to Blue et al. [36], looking at
public health practices is critical if health service planners and
evaluators are to disentangle the configuration of factors, or
hybrid of social practices, which establish healthy practices as
(im)possible or (un)desirable.
Drawing on the work of contemporary social practice theo-
rists, including Kemmis et al. [37] and Shove et al. [38], the
proposed “table of questioning” offers a strategy for facilitat-
ing analysis and action for practice-based combination HIV
prevention. The tool presents 10 questions, which in a two-
step process seek to facilitate reflection and analysis of the
range of factors that shape (dis)engagement with a particular
HIV prevention technology. The tool is by no means all encom-
passing. It merely provides a flavour of how placing emphasis
on the practice of (dis)engaging with HIV prevention technolo-
gies can offer new insight and direction for practice-based
combination HIV prevention. Practices vary in scope and size,
and the boundaries (type of technology, setting, population
group, timing), while permeable, should be established by the
objectives of the analysts [36].
The tool presents a matrix with five different types of fac-
tors across four socio-ecological levels (see Figure 1). The four
ecological levels, namely “macro,” “meso,” “micro” and individual
levels, akin to Bronfenbrenner’s socio-ecological framework
[39], have been plotted into the tool in response to a call for
greater clarity of how practices, enacted by people at a micro-
level, are positioned in macro structures [40]. The tool encour-
ages HIV prevention service planners and evaluators to first
explore the constellation of factors that affect engagement
with HIV prevention technologies for a particular population
in a particular setting (step 1). Insights from this step can then
be used to interrogate links and connections between the fac-
tors, and examine how these synergies, often in interaction
with other shared social practices, shape the ability or desire
for specific population groups to engage, or disengage, with
HIV prevention technologies (step 2). To facilitate the explo-
ration, both steps lists a series of questions. The questions
have been formulated to spark conversation about how a
practice, such as engagement with HIV prevention technolo-
gies, either emerges, persists or disappears. Reflecting the
work of Blue et al. [36] and Shove et al. [38], the questions
allow analysts to explore how best to make or break links
between defining factors; understand the competition and
collaboration that exists between the factors and associated
practices; and develop insight into how practitioners get
recruited, maintained or defected from the social practice
under scrutiny. By asking these questions, HIV prevention ser-
vice planners and evaluators will be able to explore, explain
and respond to differences in practice between people and
settings. Practically, the tool can be used figuratively to tabu-
late the range of factors and social practices associated with
engagement with a particular HIV prevention technology, or
one can draw on the questions in a variety of formats and
fora to instigate reflection and analysis, with the matrix visu-
ally reminding the analysts to consider different dimensions
and levels of analysis.
2.4 | Practice-based combination HIV prevention
for PrEP among AGYW in sub-Saharan Africa
As exemplified by the DREAMS programme [43], PrEP
increasingly forms part of the expanding portfolio of interven-
tions being made available to AGYW in sub-Saharan Africa to
prevent HIV acquisition [41,42]. The DREAMS programme
represents a breakthrough in HIV prevention in sub-Saharan
Africa, by laudably availing layers of quality and evidence-
informed interventions, covering biomedical, structural and
behavioural initiatives. Saul et al. [43: p. 12], in describing the
potential of DREAMS, argue that “meeting the needs and
demands of AGYW requires unpacking the data to identify
challenges and risks for an individual girl or young woman.
Once identified, then and only then, can a response be tai-
lored to mitigate risks in a holistic way.” Rather than imple-
menting structural, behavioural and biomedical interventions
in isolation, the DREAMS programme allow service providers
to target AGYW with a number of interventions. Promising as
this may be, it is unclear what constitutes “data,” and what
frameworks are used to ascertain which interventions to offer
particular AGYW, and with what combination-synergies. Fur-
thermore, the DREAMS programme focuses on creating an
enabling environment for HIV prevention, but pays less atten-
tion to the motivation of AGYW to engage with HIV preven-
tion practices routinely. While comprehensive, the DREAMS
programme is not exhaustive, and it is likely that local mate-
rial, symbolic, competence, relational and motivational factors,
and associated social practices that affect AGYW motivation
and capacity to engage with PrEP have not been considered.
This may either be because “data” are not available, or
because the core package interventions focus on “what works”
(evidence-informed programming), as opposed to how the
interventions work in a given context, for whom, and with
what interactions to achieve strategic advantage and synergy
[4].
The proposed “table of questioning” can help HIV preven-
tion programme planners and evaluators hone in on local
determining factors and social practices. This can help them
uncover, monitor and respond to the constellation of factors,
and related social practices that affect engagement with PrEP.
In the case of PrEP, this is important for a number of reasons.
While PrEP can reduce risk of HIV by over 90% when taken
consistently [8], PrEP trials with African women have found
adherence levels so low, particularly among young women,
that efficacy could not be ascertained [18,19]. Commentators
highlight numerous demand-side, supply-side and adherence
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barriers [25,41,44], warranting urgent attention to constella-
tions of factors and social practices that recruit and maintain
AGYW as “engagers” with PrEP. In other words, PrEP should
not merely be seen as a biomedical intervention to be
included in a combination of HIV preventions, but recognized
as a practice that is contingent on the configuration of multi-
level factors that establish engagement with PrEP as (im)pos-
sible and (un)desirable. Haberer et al. [25] argue that we must
consider the broad range of local factors that make PrEP both
relevant, appealing and available to AGYW. The proposed
“table of questioning” can help HIV prevention service plan-
ners and evaluators identify what those factors and social
practices may be. Specifically, the “table of questioning” can
help disentangle how the presence or absence of material,
symbolic, competence, relational, and motivational factors,
either enable or constrain the array of activities, or “doings,”
“sayings,” “knowings,” “relatings” and “aimings” that affect
AGYWs engagement with PrEP. What may some of these fac-
tors be?
If the public or AGYW brand PrEP as a “promiscuity pill” [45],
or consider PrEP ineffective and inappropriate for dissemina-
tion [46], this may limit demand for PrEP. Knowledge and
awareness of HIV risk is a defining element of willingness to
engage with PrEP, yet, a Zimbabwean study has found that
many young people at increased infection risk did not perceive
to be at high risk [47]. Relatedly, the FEM-PrEP study found
women to underestimate their risk of infection and that per-
ceived risk was associated with greater engagement with PrEP
[48]. Social relations and partner relations also matter. If male
partners, in contexts of male dominance, are not supportive of
their partners using PrEP, this may prevent some AGYW from
engaging with PrEP [49]. Similarly, HIV prevention service
providers may not be supportive of AGYW seeking PrEP
because of attitudes towards adolescent sexuality, and concerns
about behavioural disinhibition due to PrEP [50]. In terms of
motivational factors, a study in South Africa found that a per-
sonal desire for HIV protection, and a wish to keep engagement
with a HIV prevention technology a secret, positively affected
demand for PrEP [51]. Among HIV-uninfected Kenyan women
in serodiscordant relationships, the desire to remain HIV unin-
fected and have a HIV-free infant have also been found to moti-
vate uptake and continued use of PrEP during pregnancy [52].
Haberer et al. [25] note that adolescents and young people
live social and connected lives, which are characterized by
their quest for novelty and sensation. The everyday practices
of young people inevitably intersect with engagement with
PrEP. Scorgie et al. [53], for instance, have found both the
timing and location of young South African women’s sexual
intimacy to be unpredictable, making engagement with
on-demand oral PrEP a challenge. These factors not only differ
significantly from setting to setting, explaining varied engage-
ment with PrEP, but also interact in complex ways. If a setting
experiences drug stock-outs (perhaps due to cuts in funding),
this may not only remove a defining material factor, but also
negatively impact PrEP users trust in health services, and
acceptability of the prevention method. Comparing and con-
trasting scenarios where AGYW or other population groups at
risk are either able or unable to engage with PrEP can reveal
differences in the composition of factors and social practices
that establish engagement with PrEP as (im)possible and (un)
desirable. Such analysis can highlight the missing links, and the
actions required to avail the factors and practices that support
engagement with PrEP. For instance, if differences in the
uptake of PrEP within a country can partly be explained by
Step 1: Identify and explore factors affecting engagement with HIV prevention technologies 
Step 2: Explore and respond to interactions between 
factors and other social practices affecting engagement 
with HIV prevention technologies 
Factors affecting the practice of 
engaging with HIV prevention 
technologies 
Ecology of spatially and temporally specific factors  
6. How does the absence, presence or interactions between 
specific factors affect engagement with HIV prevention 
technologies?  
7. How can differences between populations and settings 
be explained by changes happening over time and place, 
and how might these be targeted by policy? 
8. What can be done to create, maintain or break synergies 
between different factors that affect engagement with HIV 
prevention technologies?  
9. How do shared social practices interfere with, or 
support, the practice of engaging with HIV prevention 
technologies? 
10. What factors and practices are relevant to a particular 
individual’s situation, and might be targeted by a doctor, 
nurse, community worker, parent, peers etc.? 
Macro-level Meso-level Micro-level Individual-level
1. What material factors condition the 
‘doings’ that affect engagement with 
HIV prevention technologies?  
E.g., government 




E.g., availability of 
HIV prevention 
technologies at a clinic-
level; HIV service 
provisions; guidelines 
E.g., household income;  E.g., disposable 
income; access to 
technologies; the body; 
private spaces  
2. What symbolic factors condition the 
‘sayings’ that affect engagement with 







acceptability; social and 
cultural norms; 
stigmatising attitudes 
E.g., social network 
precepts; peer and 
partner acceptability of 
the practice  
E.g., acceptability;  
principles about the 
practice; fear of stigma 
3. What competence factors condition 
the ‘knowings’ that affect engagement 
with HIV prevention technologies?  









E.g., peer and partner 
knowledge and 
perception of the 
practice;  
E.g., risk perception; 
bodily experience; 
know-how and skill 
4. What relational factors condition 
the ‘relatings’ that affect engagement 
with HIV prevention technologies?  




E.g., Community- and 





E.g., partner and power 
relations; disclosure of 
engagement with 
prevention methods;  
peers and partners 
engaging with the 
practice 
E.g., individual 





5. What motivational factors 
condition the ‘aimings’ that affect 









E.g., individual desires 
and visions 
E.g., peer, partner, and
couple desires and visions
Figure 1. A “table of questioning” for practice-based combination HIV prevention.
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differences in healthcare provider PrEP awareness, familiarity,
comfort and prescribing experiences [54], this could constitute
a missing link and avenue for action.
3 | CONCLUSIONS
Practice-based combination prevention treats HIV prevention
practices as sites of analysis and public health action. Taking a
practice-oriented approach to combination prevention enables
HIV prevention service planners and evaluators to recognize
and consider the range of factors, social practices and inter-
ventions that need to be synchronized in order to establish
engagement with HIV prevention technologies as a desirable
thing to do for particular groups of people, in specific settings.
It is a particular pertinent approach in an era of biomedical dis-
ease prevention, where the concept of “adherence” has locked
us into a narrow understanding of medicine taking and disease
self-management. Rather, practice-based combination preven-
tion calls for recognition and greater understanding of the
range and combination of factors that establish (dis)engage-
ment with HIV prevention technologies as (un)desirable and
(im)possible. It also draws attention to the role of other social
practices that are associated with engagement with HIV pre-
vention technologies. Given the low rates of PrEP uptake and
adherence among AGYW in sub-Saharan Africa, the proposed
“table of questioning” provides a much needed framework and
vocabulary to support HIV prevention service planners and
evaluators identify system-synergies [4] for PrEP engagement,
which may not otherwise be obvious.
The proposed “table of questioning” cautions against once-
size-fits-all responses, recognizing the complex realities of
people and differences in the cultural, political and socioeco-
nomic fabric of different settings. However, some factors or
interventions may well be applicable and generalizable to dif-
ferent population groups. Differentiating between global (gen-
eral) and local (specific) factors on the ecology continuum,
may reveal macro-level factors that apply to a large number
of population groups, while meso-, micro- and individual-level
factors may require more localized responses. The tool high-
lights the roles of different stakeholders in making or breaking
links to establish engagement with HIV prevention technolo-
gies as desirable and possible. Practice-based combination pre-
vention thus allow us to go beyond the biomedical
differentiated care agenda, and work towards differentiated
combination preventions. However, first, operational research
and evaluations applying and validating this tool to different
contexts is urgently needed.
AUTHOR AFF I L IAT ION
Department of Public Health, University of Copenhagen, Copenhagen, Denmark
COMPET ING INTEREST
The author has no conflicts of interest to declare.
ACKNOWLEDGEMENT
FUNDING
This work was supported by the Bill & Melinda Gates Foundation
(OPP124589).
REFERENCES
1. UNAIDS, UNAIDS Data 2018. Geneva: UNAIDS; 2018.
2. UNAIDS. Global AIDS update 2018: miles to go. Geneva: UNAIDS;
2018.
3. UNAIDS. The youth bulge and HIV. 2018. [cited 2018 Dec 18]. Available at:
http://www.unaids.org/sites/default/files/media_asset/the-youth-bulge-and-hiv_e
n.pdf
4. Brown G, Reeders D, Dowsett GW, Ellard J, Carman M, Hendry N, et al.
Investigating combination HIV prevention: isolated interventions or complex sys-
tem. J Int AIDS Soc. 2015;18(1):20499.
5. Gupta GR, Parkhurst JO, Ogden JA, Aggleton P, Mahal A. Structural
approaches to HIV prevention. Lancet. 2008;372(9640):764–75.
6. Kaufman MR, Cornish F, Zimmerman RS, Johnson BT. Health behavior
change models for HIV prevention and AIDS care: practical recommendations
for a multi-level approach. J Acquir Immune Defic Syndr. 2014;66:S250–8.
7. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumara-
samy N, et al. Antiretroviral therapy for the prevention of HIV-1 transmission.
N Engl J Med. 2016;375(9):830–9.
8. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-
exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD):
effectiveness results from the pilot phase of a pragmatic open-label randomised
trial. Lancet. 2016;387(10013):53–60.
9. Krakower DS, Jain S, Mayer KH. Antiretrovirals for primary HIV prevention:
the current status of pre-and post-exposure prophylaxis. Curr HIV/AIDS Rep.
2015;12(1):127–38.
10. Nel A, van Niekerk N, Kapiga S, Bekker LG, Gama C, Gill K, et al. Safety
and efficacy of a dapivirine vaginal ring for HIV prevention in women. N Engl J
Med. 2016;375(22):2133–43.
11. Karim QA, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor
LE, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide,
for the prevention of HIV infection in women. Science. 2010;329(5996):1168–
74.
12. Bunge KE, et al. FAME-04: a Phase 1 trial to assess the safety, acceptabil-
ity, pharmacokinetics and pharmacodynamics of film and gel formulations of
tenofovir. J Int AIDS Soc. 2018;21(8):e25156.
13. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. Ran-
domized, controlled intervention trial of male circumcision for reduction of HIV
infection risk: the ANRS 1265 Trial. PLoS Med. 2005;2(11):e298.
14. Desai M, Field N, Grant R, McCormack S, et al. State of the art review:
recent advances in PrEP for HIV. BMJ. 2017;359:j5011.
15. Amico KR, Dezzutti CS, Hendrix CW, Marzinke MA, Spiegel HML, Moncla
BJ, et al. Adherence support approaches in biomedical HIV prevention trials:
experiences, insights and future directions from four multisite prevention trials.
AIDS Behav. 2013;17(6):2143–55.
16. UNAIDS. Prevention Gap report. Geneva: The Joint United Nations Pro-
gramme on HIV/AIDS (UNAIDS); 2016.
17. Zablotska IB, Vaccher SJ, Bloch M, Carr A, Foster R, Grulich AE, et al. High
adherence to HIV pre-exposure prophylaxis and no HIV seroconversions despite
high levels of risk behaviour and STIs: the Australian demonstration study PrE-
LUDE. AIDS Behav, 2018;1–10, https://doi.org/10.1007/s10461-018-2290-3
18. Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al.
Tenofovir-based preexposure prophylaxis for HIV infection among African
women. N Engl J Med. 2015;372(6):509–18.
19. Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al.
Preexposure prophylaxis for HIV infection among African women. N Engl J
Med. 2012;367(5):411–22.
20. Ford N, Irvine C, Shubber Z, Baggaley R, Beanland R, Vitoria M, et al.
Adherence to HIV postexposure prophylaxis: a systematic review and meta-ana-
lysis. AIDS. 2014;28(18):2721–7.
21. Carrasco MA, Nguyen TQ, Kaufman MR. Low uptake of voluntary medical
male circumcision among high risk men in Malawi. AIDS Behav. 2018;22
(2):447–53.
22. Baisley K, Chimbindi N, Mthiyane N, Floyd S, McGrath N, Pillay D, et al.
High HIV incidence and low uptake of HIV prevention services: the context of
risk for young male adults prior to DREAMS in rural KwaZulu-Natal, South
Africa. PLoS One. 2018;13(12):e0208689.
23. Grund JM, Grund JM, Davis SM, Ridzon R, Mattingly M, Wilkinson J, et al.
Systematic review of the effect of economic compensation and incentives on
uptake of voluntary medical male circumcision among men in sub-Saharan
Africa. AIDS Care. 2018;30(9):1071–82.
24. Toska E, Cluver L. Barriers to U=U for adolescents living with HIV: predic-
tors of high HIV-transmission risk from a longitudinal cohort study in 2nd Inter-
national Workshop on HIV Adolescence-Challenges & Solutions. 2018: Cape
Town, South Africa.
Skovdal M Journal of the International AIDS Society 2019, 22(S4):e25294
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25294/full | https://doi.org/10.1002/jia2.25294
18
25. Haberer JE, Mugo N, Baeten JM, Pyra M, Bukusi E, Bekker LG. PrEP as a
Lifestyle and Investment for Adolescent Girls and Young Women in Sub-Saharan
Africa. J Int Assoc Provid AIDS Care. 2019;18:1–5.
26. Zimmerman RS, Noar SM, Feist-Price S, Dekthar O, Cupp PK, Anderman E,
et al. Longitudinal test of a multiple domain model of adolescent condom use. J
Sex Res. 2007;44(4):380–94.
27. Latkin C, Weeks MR, Glasman L, Galletly C, Albarracin D. A dynamic social
systems model for considering structural factors in HIV prevention and detec-
tion. AIDS Behav. 2010;14(2):222–38.
28. Johnson BT, Redding CA, DiClemente RJ, Mustanski BS, Dodge B, Sheeran
P, et al. A network-individual-resource model for HIV prevention. AIDS Behav.
2010;14(2):204–21.
29. Garnett GP, Hallett TB, Takaruza A, Hargreaves J, Rhead R, Warren M,
et al. Providing a conceptual framework for HIV prevention cascades and
assessing feasibility of empirical measurement with data from east Zimbabwe: a
case study. Lancet HIV. 2016;3(7):e297–306.
30. Hargreaves JR, Delany-Moretlwe S, Hallett TB, Johnson S, Kapiga S, Bhat-
tacharjee P, et al. The HIV prevention cascade: integrating theories of epidemio-
logical, behavioural, and social science into programme design and monitoring.
Lancet HIV. 2016;3(7):e318–22.
31. Moorhouse L, et al. Application of the HIV prevention cascade to identify,
develop, and evaluate interventions to improve use of prevention methods:
examples from a study in east Zimbabwe. J Int AIDS Soc. 2019;22(S3):e25309.
32. Brown G, Reeders D, Cogle A, Madden A, Kim J, O’Donnell D. A systems
thinking approach to understanding and demonstrating the role of peer-led pro-
grams and leadership in the response to HIV and hepatitis C: findings from the
W3 project. Front Public Health. 2018;6:231.
33. Kippax S. Effective HIV prevention: the indispensable role of social science.
J Int AIDS Soc. 2012;15(2):17357.
34. Kippax S, Stephenson N, Parker RG, Aggleton P. Between individual agency
and structure in HIV prevention: understanding the middle ground of social
practice. Am J Public Health. 2013;103(8):1367–75.
35. Reckwitz A. Toward a theory of social practices a development in culturalist
theorizing. Eur J Soc Theory. 2002;5(2):243–63.
36. Blue S, Shove E, Carmona C, Kelly MP. Theories of practice and public health:
understanding (un) healthy practices. Crit Public Health. 2016;26(1):36–50.
37. Kemmis S, Wilkinson J, Edwards-Groves C, Hardy I, Grootenboer P, Bristol
L. Changing practices, changing education. London: Springer Science & Business
Media; 2013.
38. Shove E, Pantzar M, Watson M. The dynamics of social practice: everyday
life and how it changes. London: Sage Publications; 2012.
39. Brofenbrenner U. The ecology of human development : experiments by nature
and design. Cambridge, MA: Harvard University Press; 1979. xv, 330 p.
40. Nicolini D. Is small the only beautiful? Making sense of ‘large phenomena’
from a practice-based perspective, in The Nexus of Practices. New York: Rout-
ledge; 2016. 110-125.
41. Baxter C, Abdool Karim S. Combination HIV prevention options for young
women in Africa. Afr J AIDS Res. 2016;15(2):109–21.
42. Hosek S, Pettifor A. HIV prevention interventions for adolescents. Curr
HIV/AIDS Rep. 2019;16(1):120–128.
43. Saul J, Bachman G, Allen S, Toiv NF, Cooney C. The DREAMS core
package of interventions: a comprehensive approach to preventing
HIV among adolescent girls and young women. PLoS One. 2018;13(12):
e0208167.
44. Cowan FM, Delany-Moretlwe S, Sanders EJ, Mugo NR, Guedou FA, Alary
M, et al. PrEP implementation research in Africa: what is new? J Int AIDS Soc.
2016;19(7S6):21101.
45. Mugo NR, Ngure K, Kiragu M, Irungu E, Kilonzo N. PrEP for Africa: what
we have learnt and what is needed to move to program implementation. Curr
Opin HIV AIDS. 2016;11(1):80.
46. Rubincam C, Newman PA, Atujuna M, Bekker LG. ‘Why would you promote
something that is less percent safer than a condom?’: perspectives on partially
effective HIV prevention technologies among key populations in South Africa.
SAHARA J. 2018;15(1):179–86.
47. Schaefer R, Thomas R, Nyamukapa C, Maswera R, Kadzura N, Gregson S.
Accuracy of HIV risk perception in East Zimbabwe 2003–2013. AIDS Behav.
2018;1–11; https://doi.org/10.1007/s10461-018-2374-0
48. Corneli A, Perry B, Agot K, Ahmed K, Malamatsho F, Van Damme L. Facili-
tators of adherence to the study pill in the FEM-PrEP clinical trial. PLoS One.
2015;10(4):e0125458.
49. Govender E, Abdool Karim Q. Understanding women and men’s acceptabil-
ity of current and new HIV prevention technologies in KwaZulu-Natal, South
Africa. AIDS Care. 2018;30(10):1311–4.
50. Pilgrim N, Jani N, Mathur S, Kahabuka C, Saria V, Makyao N, et al. Provi-
der perspectives on PrEP for adolescent girls and young women in Tanzania:
the role of provider biases and quality of care. PLoS One. 2018;13(4):
e0196280.
51. Govender E, Mansoor L, MacQueen K, Abdool Karim Q. Secrecy, empower-
ment and protection: positioning PrEP in KwaZulu-Natal, South Africa. Cul
Health Sex. 2017;19(11):1268–85.
52. Pintye J, Beima-Sofie KM, Kimemia G, Ngure K, Trinidad SB, Heffron RA,
et al. “I Did Not Want to Give Birth to a Child Who has HIV”: experiences using
prep during pregnancy among HIV-uninfected Kenyan women in HIV-serodis-
cordant couples. J Acquir Immune Defic Syndr. 2017;76(3):259–65.
53. Scorgie F, Stadler J, Baron D, Ju S, Ikaneng T, Mabude Z, et al. “It Was Not
My Aim to Sleep There”: the impact of timing and location of sex on adherence
to coitally-dependent HIV pre-exposure prophylaxis. AIDS Behav. 2018;22
(11):3692–704.
54. Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA.
PrEP awareness, familiarity, comfort, and prescribing experience among US
primary care providers and HIV specialists. AIDS Behav. 2017;21(5):
1256–67.
Skovdal M Journal of the International AIDS Society 2019, 22(S4):e25294
http://onlinelibrary.wiley.com/doi/10.1002/jia2.25294/full | https://doi.org/10.1002/jia2.25294
19
